Affinity Asset Advisors, LLC CRNX Holdings History
Affinity Asset Advisors, LLC's Crinetics Pharmaceuticals Inc Holding Summary
As of 2025-03-31, Affinity Asset Advisors, LLC held 152,252.00 shares of Crinetics Pharmaceuticals Inc(CRNX), totaling $5.11 Mil. This investment constitutes 0.5% of their stock portfolio, and Affinity Asset Advisors, LLC now holds 0.16% of the outstanding Crinetics Pharmaceuticals Inc(CRNX) stock.
The initial trade took place in 2023Q3. And since then Affinity Asset Advisors, LLC has made 4 purchases of CRNX, at an average price of $27.01, for a total of 577,905.00 shares. In addition, there have been 3 sales at an average price of $41.15 for 425,653.00 shares. Based on historical transaction data and CRNX's current price of $29.20, Affinity Asset Advisors, LLC's estimated gain on his CRNX holdings is $6.35 Mil, reflecting a 40.68% gain to date.
Affinity Asset Advisors, LLC CRNX ($29.20) Holding Chart
Affinity Asset Advisors, LLC CRNX ($29.20) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price $-/Share | ||
| Shares Sold | 0 | Average Price $-/Share | ||
| Current Price $0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
